Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease.
about
Cytomegalovirus-induced immunopathology and its clinical consequencesResistance of human cytomegalovirus to antiviral drugs.Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection.Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Risk Factors for Primary Infection and Cases of Recurrent and Late Infection at a Single Center.Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associatedCytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantationCognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantationDistinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease.Cytomegalovirus infection according to cell source after hematopoietic cell transplantation in pediatric patientsSirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysisCytomegalovirus in hematopoietic stem cell transplant recipientsThe status of CMV as a human pathogen.Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipientsImpact of pretransplant donor and recipient cytomegalovirus serostatus on outcome for multiple myeloma patients undergoing reduced intensity conditioning allogeneic stem cell transplantation.Utility of the Enzyme-Linked Immunospot Interferon-γ-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients.Increase in severity of graft versus host disease by cytomegalovirus.Active human cytomegalovirus infection and glycoprotein b genotypes in brazilian pediatric renal or hematopoietic stem cell transplantation patients.Cytomegalovirus pneumonia in hematopoietic stem cell recipients.How we treat cytomegalovirus in hematopoietic cell transplant recipients.The risk factors for cytomegalovirus reactivation following stem cell transplantation.Viral Pneumonia in Patients with Hematologic Malignancy or Hematopoietic Stem Cell Transplantation.Current thoughts on the pathogenesis of graft versus host disease.Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: functional analyses of lymphocytes and correlation with immunophenotypic recovery following transplantation.Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity.Assessment of the Human Cytomegalovirus UL97 Gene for Identification of Resistance to Ganciclovir in Iranian Immunosuppressed PatientsA Low Incidence of Cytomegalo Virus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation Despite a High Seroprevalence
P2860
Q21195897-307381BE-0FBE-4E39-8E6E-16C5CCACD007Q33588911-43F91F4B-DEB1-4EB4-AAE9-3790754EAF69Q33809769-12491482-9DA5-41FD-BF18-E97C5DF7EAB8Q33853830-310B9BB7-3FCB-44BB-AACD-CF07568734C6Q34626390-85F14E1F-281A-4D96-AFBB-B4F36151A15EQ34809933-440BAAC5-4890-4995-B433-75FD8272BB69Q34991001-4766DE3C-737B-4786-BAD7-A1627554FF2BQ35230656-BAAEFC71-808F-4036-B4BE-B67EDEBC3F4AQ35767479-663539E7-9452-497B-BC9F-0C7A11131791Q35900978-5B0CA277-1FD7-482D-B2A8-B6E67471AC79Q35922928-76C86D6E-7B00-404F-AEEB-F829668D3FE7Q36472493-DAE4CBA7-F1EC-44F1-8AB4-420AE0F29284Q36611167-90FF3984-8FC9-437F-BCE1-415C15B99470Q36826198-808F38CE-6487-4047-A3C7-96AB057A648DQ36871982-751AB34B-61B7-48E8-A368-A17B81CA07B9Q37111493-E14422CE-35F2-4DCF-A424-7A8075622B9EQ37159472-2711BC57-1B34-4C9B-9137-D40371673A70Q37179131-96F40DCA-8846-401B-8918-106918CFDA5CQ37237427-28C692F7-68F2-49A5-8DDD-091A5446C2CFQ38751030-ABCD6A47-EACC-40D0-8482-D6DA50B80B86Q39118448-C0BFD527-5C5E-407A-8942-666DFFCCF99DQ39619946-DD8D778F-06AF-4D29-B82A-757A98E34079Q39811083-95B2872F-E813-49B5-9597-DA1D85A9B158Q39820778-7D9A6A74-A9B4-4113-9309-B566AB216E42Q40096975-7B6B4418-167E-4268-8BBF-AF2496ACDE98Q40570063-C786E8BF-2B96-4C8D-84F9-3D930F164BB4Q58125059-08665C33-789C-4F5C-817B-4CA3C3E22DF7
P2860
Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Cytomegalovirus infection afte ...... th acute graft-v-host disease.
@en
Cytomegalovirus infection afte ...... th acute graft-v-host disease.
@nl
type
label
Cytomegalovirus infection afte ...... th acute graft-v-host disease.
@en
Cytomegalovirus infection afte ...... th acute graft-v-host disease.
@nl
prefLabel
Cytomegalovirus infection afte ...... th acute graft-v-host disease.
@en
Cytomegalovirus infection afte ...... th acute graft-v-host disease.
@nl
P2093
P1433
P1476
Cytomegalovirus infection afte ...... th acute graft-v-host disease.
@en
P2093
Balfour HH Jr
McCullough J
P304
P407
P577
1986-04-01T00:00:00Z